Literature DB >> 30454833

Alcohol Use Disorders in Alcoholic Liver Disease.

Jessica L Mellinger1, Gerald Scott Winder2.   

Abstract

Alcohol use disorder (AUD) is common in alcoholic liver disease (ALD) and intrinsic to its pathophysiology. Optimal treatment requires a multidisciplinary team approach and a working alliance between patients and providers. Diagnosing AUD involves a combination of thorough history taking, physical examination, screening questionnaires, and alcohol biomarkers. Alcohol biomarkers have advantages and limitations of use of which clinicians should be aware. AUD treatment is effective, multifaceted, and can be tailored to each individual. Available treatment modalities are myriad: motivational enhancement therapy, cognitive behavior therapy, 12-step facilitation, group therapies, intensive outpatient programs, inpatient and residential treatment, and relapse prevention medications.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Addiction; Alcohol dependence; Biomarkers; Multidisciplinary care

Mesh:

Substances:

Year:  2019        PMID: 30454833     DOI: 10.1016/j.cld.2018.09.004

Source DB:  PubMed          Journal:  Clin Liver Dis        ISSN: 1089-3261            Impact factor:   6.126


  5 in total

Review 1.  The knowns and unknowns of treatment for alcoholic hepatitis.

Authors:  Tejasav S Sehrawat; Mengfei Liu; Vijay H Shah
Journal:  Lancet Gastroenterol Hepatol       Date:  2020-05

Review 2.  Behavioral Treatment for Patients With Alcohol-Related Liver Disease: A Primer for Hepatologists.

Authors:  Peng-Sheng Ting; Jason Wheatley; Po-Hung Chen
Journal:  Clin Liver Dis (Hoboken)       Date:  2020-02-25

Review 3.  Alcohol misuse in patients with alcohol-related liver disease: How can we do better? A narrative review of the literature.

Authors:  Jane Horrell; Lynne Callaghan; Ashwin Dhanda
Journal:  Alcohol Clin Exp Res       Date:  2022-07-08       Impact factor: 3.928

Review 4.  Moderate Alcoholic Hepatitis.

Authors:  Ana Clemente-Sánchez; Aline Oliveira-Mello; Ramón Bataller
Journal:  Clin Liver Dis       Date:  2021-05-27       Impact factor: 6.265

5.  Substance Use Disorders in Recently Hospitalized Patients With Cirrhosis.

Authors:  Lamia Y Haque; Simona Jakab; Yanhong Deng; Maria M Ciarleglio; Jeanette M Tetrault
Journal:  J Addict Med       Date:  2020-12       Impact factor: 4.647

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.